Questcor Pharmaceuticals appoints senior VP
This article was originally published in Scrip
Executive Summary
Questcor Pharmaceuticals, which develops treatments for autoimmune and inflammatory disorders, has named Michael Aldridge senior vice-president, corporate strategic development. Prior to joining California, US-based Questcor, Mr Aldridge served as chief executive officer, managing director and board member of Australian biopharma, Xenome. He will report to Questcor’s chief operating officer, Steve Cartt.